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Abstract
Because of the increasing age of the population, critical care and emergency medicine physicians have seen an
increased number of critically ill patients over the last decade. Moreover, the trend of hospital closures in the
United States t imposes a burden of increased efficiency. Hence, the identification of devices that facilitate accurate
but rapid assessments of hemodynamic parameters without the added burden of invasiveness becomes
tantamount. The purpose of this review is to understand the applications and limitations of these new
technologies.
Review
The ultimate goal of any hemodynamic monitoring sys-
tem is to provide the clinicians with additional informa-
tion on the underlying pathological condition and to
guide fluid or vasopressor therapy. Cardiac output mea-
surement and its response to therapeutic interventions
are frequently used in critically ill patients. As the use of
CO monitoring devices increases today, it is necessary to
understand the application of such devices in different
clinical settings. For many years pulmonary artery cathe-
ter (PAC) thermodilution cardiac output assessment was
the monitor of choice for the management of critically
ill patients. Thermodilution is a modification of the ori-
ginal indicator dilution techniques in which the injectate
has a defined volume and temperature from which the
thermodilution curve is generated [1]. As with the other
indicator dilution techniques, CO is calculated from the
area under the indicator thermodilution curve using the
modified Stewart-Hamilton equation [2]. PAC was first
used in dogs, and subsequently in humans 50 years later
[2]. PAC provides valuable measurements, including
right atrial pressure, right ventricular pressures, pulmon-
ary artery pressures, pulmonary artery occlusive pres-
sure, mixed venous saturation (SvO2), and CO. The
derived hemodynamic variables are systemic and pul-
monary vascular resistances. The major obstacle for the
use of PAC has been the lack of demonstrating patient
benefit and its level of invasiveness. Several prospective
trials have demonstrated the lack of benefit from PACs.
The PAC-man trial indicated that the routine placement
of PACs had no effect on morbidity or mortality, and
the ESCAPE trial found no difference in mortality or
length of hospital stay when PAC parameters were com-
pared with clinical assessment in the management of
severe congestive heart failure patients [3-6]. Further-
more, for using PAC now, many physicians have lost
the training, confidence, and familiarity with its use.
PAC should probably be used only in selected patients
by experienced practitioners. Contraindications to the
insertion of PAC include tricuspid or pulmonary valve
endocarditis/mechanical valve and right heart mass or
thrombus. Like the PAC, each of these newer monitor-
ing modalities requires education and training for effec-
tive use. For emergency room physicians, each
technology provides a set of advantages and limitations.
Minimally invasive cardiac output monitors allow for
time efficiency in the emergency department setting and
provide valuable information regarding the overall cardi-
ovascular status of the patient. Declining cardiac index
in trauma patients may indicate the need for revaluation
of the patient. In general, early goal-directed therapy is
usually better in the early phase of critical illness in con-
trast to late stages for sick patients. Minimally invasive
monitoring devices for optimal CO and global oxygen
balance may be of particular interest for emergency
medicine physicians in the perioperative setting, acute
lung injury, hypothermia induction, or preload and fluid
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responsiveness assessment in the management of septic
shock and acute respiratory distress syndrome. Cur-
rently the evidence and literature have not necessarily
caught up with the trends in the US and Europe with
these devices, and partts of the article represent the
authors’ experience.
Minimally invasive CO monitors
CO monitors use different principles for measuring CO.
They include Doppler technology, echocardiography,
pulse contour analysis, transpulmonary thermodilution,
bioimpedance, bioreactance and Fick’s principle.
Esophageal Doppler
Esophageal Doppler (ED) measuring aortic blood flow
velocity was first introduced in 1971 [7]. The ED monitor
measures the velocity of blood flow in the descending
thoracic aorta using a flexible ultrasound probe. When
combined with the aortic cross-sectional area it allows
measurement of stroke volume and CO. The aortic dia-
meter is obtained from a built-in nomogram or by direct
measurement using M-mode echocardiography. A meta-
analysis of several trials in critically ill patients showed
high validity, but they were all performed in stable hemo-
dynamic patients [8]. This meta-analysis suggested that
ED was good at determining trends in CO but less effec-
tive in measuring absolute CO. The main application of
this device has been for preload optimization, myocardial
contractibility and goal-directed fluid therapy for surgical
patients (Figure 1) [9-11]. ED can be safely utilized in
emergency departments. In the study by Rodriguez et al.
[12], they demonstrated in a prospective manner that
cardiac output evaluation using ED in the emergency
room was superior to physician estimation of cardiac
output. He concluded that esophageal Doppler measure-
ment of CO/CI appears to be practical from a physician
time standpoint. Marquez et al. [13] demonstrated good
correlation between ED and the LIDCO devices in car-
diac surgery patients. Seoudi et al. prospectively investi-
gated the correlation between PAC and ED in surgical
trauma. On the basis of this study, it is reasonable to con-
clude that the ED is a valuable adjunct technology for CO
and preload assessment for patients in the emergency
medicine ward on mechanical ventilation, regardless of
the level of mechanical ventilatory support [14]. The cur-
rent literature supports the use of ED for assessment of
cardiac output and left ventricular filling pressure
[15-17]. This device is operator dependent, and place-
ment of the probe in the wrong position can alter the CO
reading. Additional limitations include the need for intu-
bation of the trachea, expense, inaccurate CO in patients
with aortic regurgitation, and the assumption that the
division of the blood flow from the descending aorta is
constant with even distribution to the brachiocephahlic
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Figure 1 Esophageal Doppler has the ability to measure flow time and peak velocity. The flow time is the time from the beginning of
aortic pulse waveform upstroke to its return to baseline. A. Peak velocity is a good indicator of myocardial contractibility (normal). B. The left
ventricular ejection time (or flow-time) corrected for heart rate provides an index of preload (hypovolemia). C. Left ventricular failure. Note that
during hypovolemia and heart failure the stroke distance is decreased.
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and coronary arteries. This assumption is not always true
in very ill patients.
Echocardiography
Echocardiography has been used in the ICU and emer-
gency medicine for many years to diagnose the underly-
ing cause of hemodynamic instability. Like ED,
echocardiography uses Doppler technology, but it relies
on direct visualization of the cardiac anatomy and flow
dynamics. The American College of Emergency Physi-
cians encourages emergency medicine physicians to be
able to rapidly diagnose pericardial tamponade and elec-
tromechanical dissociation, which represent truly emer-
gent and potentially lethal cardiovascular conditions. A
focused point of care exam will enable the emergency
medicine physician to quickly assess: hemodynamic
states [18] and unexplained hypotension [19], congestive
heart failure, pericardial effusion, and pulmonary emboli
[20]. In addition, it provides an emergency medicine
physician an important tool to assess the efficiency of
resuscitation and ultimately improve patient outcome
[21]. Moreover, if the causes of circulatory failure are
obscure, echocardiography provides the ability to evalu-
ate structural abnormalities such as:
1. Wall motion abnormality for the diagnosis of
myocardial injury [22] and evaluation of cardiac pre-
load by estimating inferior vena cava (IVC) collapsi-
bility [23].
2. Ventricular systolic dysfunction [24] and cardiac
output (Figure 2).
One potential disadvantage of this device is the addi-
tional training required to make a proper diagnosis.
Detailed cardiac echocardiography for diagnosis of com-
plex cardiac diseases requires more advance training.
Echocardiography measures CO only in a single point in
time and is not suitable for trend analysis.
 
Figure 2 Blood leaves the left ventricular outflow tract (LVOT) as a cylinder (aorta shown in red). The volume of the cylinder is equal to
the stroke volume (SV). In order to calculate SV, the echocardiographer must obtain the diameter of the LVOT and velocity time integral (VTI) of
the blood measured at the same exact location. Ao = Aorta, LV = left ventricle, RV = right ventricle, LA = left atrium.
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Pulse contour analysis
Pulse contour analysis of cardiac output is based on the
principles that stroke volume can be continuously esti-
mated by analyzing the arterial pressure waveform
obtained from an arterial line. The origin of the pulse
contour method for estimation of the beat-to-beat
stroke volume is based on the Windkessel model
described by Otto Frank in 1899. In 1974, Wesseling et
al. developed an algorithm that can be used to monitor
stroke volume (SV) [25]. CO is calculated from the area
under the curve of the systolic portion of the arterial
pressure waveform divided by the aortic impedance
multiplied by the heart rate. Currently, there are differ-
ent commercially available devices that measure CO
based on the pulse contour analysis method.
The most frequently used ones are the calibrated
PiCCO monitor system (PULSION Medical Systems,
Munich, Germany), the LiDCO monitoring system
(LiDCO Ltd., London, UK), which is available as either a
calibrated (LiDCOplus) or uncalibrated device (LiDCOr-
apid), and the uncalibrated FloTrac/Vigileo device
(Edwards Life Sciences, Irvine, CA). The pulse contour
devices are utilized with greater frequency in our local
practice; hence, they are covered in more detail.
PiCCO system
The PiCCO system uses the pulse contour method
based on the Wesseling algorithm for the calculation of
CO. The system is periodically calibrated via the ther-
modilution method to calibrate the pulse pressure algo-
rithm. PiCCO is a cardiac monitor that measures
cardiac output and several volumes such as intrathoracic
blood volume (ITBV), global end diastolic volume
(GEDV), and extra vascular lung water (EVLW) [26].
PiCCO can also provide pulse contour parameters,
which consist of continuous CO, systemic vascular resis-
tance (SVR), stroke volume variation (SVV), and pulse
pressure variation. The PiCCO system requires a ther-
mistor-tipped central venous catheter and an arterial
line usually introduced via the femoral, axillary, or bra-
chial artery. After central venous injection of the cold
indicator, the thermistor in the tip of the arterial cathe-
ter measures the downstream temperature changes. The
CO is then calculated by analysis of the thermodilution
curve using a modified Stewart-Hamilton algorithm.
Pulse contour analysis continuously measures stroke
volume and arterial pressure. CO and systemic vascular
resistance (SVR) are calculated (Figure 3). Different stu-
dies in a variety of clinical settings have been performed
in recent years validating the PiCCO system against
intermittent pulmonary artery thermodilution (ITD)
[27,28]. Goal-directed therapy with this technology has
been reported in patients undergoing CABG surgery
[29] and for preload optimization [30,31]. In the study
by Uchino et al., the use of PiCCO was associated with
a greater positive fluid balance and fewer ventilator-free
days. After correction for confounding factors, the
choice of monitoring did not influence major outcomes,
whereas a positive fluid balance was a significant inde-
pendent predictor of outcome [32]. This device has
mainly been utilized in critical care setting but
PiCCO has the ability to measure (ITBV), (EVLW),
and cardiac function index (CFI). These parameters are
of interest as they are considered to be the most specific
measures of cardiac preload, pulmonary edema, contrac-
tility, and a global indicator of cardiac performance.
Figure 3 PiCCO system: Stroke volume is the area under systolic portion of arterial pulse waveform (shaded). Stroke volume is
calculated = [area under systolic phase (shaded) + aortic compliance] × shape of pressure curve.
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Therefore, PiCCO may give an emergency medicine
physician a powerful tool for managing critically ill
patients [29].
Flo-Trac
Flo-Trac is another pulse contour CO monitoring sys-
tem (Vigileo, Edwards Life Sciences) that was introduced
in 2005. A special blood flow sensor, which is connected
to an arterial line (radial, brachial, axillary or femoral
artery), is needed. No external calibration is necessary
[33-35]. This device calculates CO on a continuous
basis by multiplying the pulse rate by calculated stroke
volume. The direct relationship between arterial pulsati-
lity and the stroke volume is used to calculate CO.
Based on the model described by Langewouters et al.
[36] individual demographics (body surface area, age,
gender) are used for estimation of aortic compliance.
Vascular compliance and resistance are determined
using arterial waveform analysis. Several studies
[33,37,38] have been performed concerning the accuracy
of Vigileo CO monitoring in a variety of patients with
different software versions of the device. The Vigileo
monitor has been used in emergency medicine setting
for resuscitation of burn victims with good result [39].
Stroke volume variation on this monitor can help clini-
cians to assess fluid responsiveness in the initial phase
of septic shock. However, rapid changes in vascular
motor tone may lead to impaired accuracy of CO moni-
toring. Flow-Trac accuracy is worse with arterial wave
artifact, compromise of the arterial catheter, aortic
regurgitation, intense peripheral vasoconstriction, irregu-
lar pulse, and severe cardiac hypo-function. Thus, its
reliability is influenced by various conditions, especially
in critically ill patients [40].
Lithium dilution CO
The technique of using lithium dilution to measure CO
was first described in 1993 by Linton et al. [41]. This
technique uses pulse contour analysis for CO measure-
ment and lithium dilution for system calibration. A
small dose of lithium is injected into a peripheral vein,
and an ion selective electrode is attached to a peripheral
arterial line. The area under the curve of a plot of
lithium concentration against time allows accurate cal-
culation of the CO. The lithium dilution technique is of
sufficient accuracy when there is constant blood flow
and uniform mixing of blood. There are advantages and
limitations to this technology, discussed in detail by
Pearse et al. [42]. Other groups have demonstrated the
accuracy of LIDCO [43]. Costa et al. showed good
agreement among the LiDCO, PAC, and PICCO systems
[44]. The major limitation to this device is the need for
repetitive blood draws and, in the presence of neuro-
muscular blocking drugs, interference with calibration.
Bioimpedance
The use of the electrical signal across the thorax to
measure CO goes back to early 1970 [45]. Bioimpedance
technology uses electrical resistance charges across the
chest for identification of cyclic changes in blood flow.
CO is then continuously estimated by analyzing beat-to-
beat signal variation. CO calculation is based on differ-
ent mathematical models. Early studies demonstrated
only a fair correlation between thoracic electrical impe-
dance (TEB) and thermodilution CO [46]. Despite many
adjustments of the mathematical algorithms, validation
studies continue to show mixed results [47]. In addition,
TEB accuracy decreases with excessive lung water and
pulmonary edema [48]. In recent years advances in
bioimpedence technology have resulted in development
of a novel technology placing the electrodes on endotra-
cheal tube cuff (ECOM, CONMED, Utica, NY, USA).
The proximity of the ascending aorta and trachea facili-
tated the design of this device. It can optimize the cur-
rent delivery and signal recording from changes in the
ascending aorta [49]. Because the tracheal mucosa pro-
duces mucous and fluid, the endotracheal cardiac output
monitor (ECOM) electrodes have been designed to
reduce the effects of fluid and mucous buildup. This
device appears promising, and preliminary data indicate
adequate reliability of this device [49-51]. The main dis-
advantage of ECOM is the need for an endotracheal
tube and mechanical ventilation. ECOM can be used in
emergency medicine for preload assessment and
response to vasopressor therapy.
Bioreactance
Bioreactance (NICOM; Cheetah Medical, Vancouver,
WA, USA) is a unique technology for assessment of car-
diac output [52]. It is similar to bioimpedance in that
electrical current is applied to the chest via two leads.
The bioreactance technique analyzes the frequency var-
iations of the delivered oscillating current. This will
result in a higher signal-to-noise ratio, and thus result
in improved performance of the device. There have
been several studies comparing the NICOM monitor to
other monitors (PiCCO, Flo-Trac, PAC). These studies
showed high agreement with the various monitors
[52-56]. This device has very few known disadvantages
and can be used in variety of settings.
Fick’s principle
Adolf Fick spent most of his life studying muscle meta-
bolism, but in a brief publication in 1870, he described
how mass balance might be used to measure cardiac
output [57]. Later Guyton et al quoted the original work
and expanded upon it [58]. It is based on the conserva-
tion of mass, such that the total uptake or release of a
substance by an organ is the product of the blood flow
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to that organ multiplied by the arteriovenous concentra-
tion difference [59]. CO by modified Fick’s method mea-
sures carbon dioxide (CO2) production and exhaled or
end tidal CO2 at baseline and during a brief period of
rebreathing. This will allow calculation of pulmonary
artery blood flow. A new monitor called the NICO sys-
tem (Novametrix Medical Systems, Wallingford, CT)
uses Fick’s equation for CO2 elimination. It is relatively
noninvasive. Its principle states that over a fixed period
of time the amount of CO2 leaving the lungs in the
arterial blood is equal to the amount brought into the
lungs in the venous blood minus the amount eliminated
through the lungs. With this method, the CO is com-
puted on breath-by-breath measurements of CO2 elimi-
nation. CO is proportional to the change in CO2
elimination divided by the change in end tidal CO2
resulting from a brief rebreathing period. Rebreathing
measurements are made every 3 min for 35 s. The main
drawback to this system is the assumption about the
shunt fraction and arterial CO2 being equal to end-tidal
CO2. Clinical and experimental data for CO determina-
tions with the NICO monitor [60] give a better approxi-
mation of CO in patients who are less critically ill and
have normal alveolar gas exchange. Additionally, preload
optimization may be difficult using the NICO monitor,
and caution should be exercised before using this moni-
tor for fluid administration. Potentially large volumes of
fluid may be administered to achieve desired endpoints
[61]. Advantages of NICO include the easy setup and
providing capillary blood flow and ventilator parameters,
such as the ratio of tidal volume to dead space. The
NICO monitor assumes that the partial venous CO2
concentration reflects the level of CO2 stored in the
body. Therefore, any changes in metabolism or ventila-
tion may alter the reliability of this monitor. Pulmonary
shunting and heterogeneous ventilation decrease the
Table 1 Cardiac output monitors
Advantages Disadvantages
PAC Pulmonary infarction
Measure CVP Rupture of pulmonary artery
Intermittent and continuous Arrhythmias








Intermittent and continuous Cannot be used if patient on lithium or NDM
SVR can be obtained Need frequent blood drawing
Does not estimate preload
C. Flo-trac SVR can be obtained Not reliable in very high CO state
Measure PPV/SVV Perform poorly with tachyarrhythmia
Many validation studies Valvular pathology prevents accurate reading of CO
Esophageal Doppler Less invasive Needs intubated patient
Simple to use Only measure descending aortic flow
Not good in AR
Echocardiography Provides detailed cardiac information Needs additional training
Estimate preload Inability to image patient
Bioreactance Non-invasive Numerous mathematical assumptions
Continuous Signal stability fails after 24 h
Sensors can be placed anywhere in thorax and back
Bioimpedence Continuous Numerous mathematical assumptions
Difficult to set up Signal stability fails after 24 h
Flick’s Principle Easy set up Not suitable for unstable patient
Provides additional ventilatory parameters Shunt can affect CO estimation
CVP central venous pressure, BP blood pressure, CO cardiac output, PCA pulse contour analysis, ICU intensive care unit, SVV stroke volume variation, PPV pulse
pressure variation, GEDV global end diastolic volume, EVLW extravascular lung water, SVR systemic vascular resistance, CO cardiac output, AR aortic regurgitation,
NDM non-depolarizing muscle relaxant, PAC pulmonary artery catheter
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precision of this device in acute lung injury since the
shunt fraction is estimated from the concentration of
the inspired fraction of oxygen and arterial oxygen
saturation. Its main area of use has been in stable car-
diac patients. This device can be utilized in the busy
emergency medicine environment for evaluation of low
cardiac output states if a patient is already intubated
and on mechanical ventilation.
Conclusions
With an increasing need for utilization of hemodynamic
monitoring due to the aging population, increased
comorbidities and increasingly complex interventions
and monitoring are becoming incorporated into the
standard of care, and the need for hemodynamic moni-
toring is likely to increase. Because of the inherent lim-
itations and complications of PAC in the busy
emergency department, physicians are looking for less
invasive devices to measure CO. There is no gold stan-
dard for the clinical measurement of CO. Therefore,
comparison of these new technologies is somewhat chal-
lenging (Table 1). The level of invasiveness and com-
plexity may help the clinicians decide where to best use
the devices (Figure 4).
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Figure 4 Suggested use of cardiac output devices and monitoring system within the hospital system. ER = Emergency room, OR/PACU =
operating room/post-anesthesia care unit, SDU = step down unit, ICU = intensive care unit, ECOM = endotracheal cardiac output monitoring.
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